were determined.
McKean, C. M. (1971) . Archives of Disease in Childhood, 46, 608. Effects of totally synthetic, low phenylalanine diet on adolescent phenylketonuric patients. The long-term responses of 5 adolescent phenylketonuric patients to chemically-defined, synthetic diets with normal and low phenylalanine content were determined.
The synthetic preparations were found capable of sustaining good health and rapid growth in this group of profoundly retarded, behaviourally disturbed patients over a 3j-year period without clinical or biochemical evidence of nutritional inadequacy.
4 of these patients who were treated for 6 months on a comparable diet, in which 80% of the phenylalanine was replaced by tyrosine, continued to show weight maintenance and height increases. There was no evidence of poor acceptability of the imbalanced diet, whether the blood phenylalanine concentrations were at phenylketonuric or treatment levels. The phenylalanine intake required to maintain blood phenylalanine concentrations of 3-5 mg/100 ml in these 4 patients was well below normal requirements, and ranged between 6-8 and 20 1 mg/kg per day. Predictably, the phenylalanine requirement varied with individual growth rates.
All 4 treated patients had objective signs of improved central nervous system function during the six-month period on the phenylalanine-restricted diet. These electrophysiological and behavioural improvements were manifest after blood phenylalanine concentrations fell below 12 mg/100 ml in 3 cases and below 5 mg/ 100 ml in the fourth.
The enthusiasm that followed Bickel's first report (Bickel, Gerrard, and Hickmans, 1953) on the successful dietary treatment of phenylketonuria in 1953 has been tempered recently by an increasing awareness of the hazards implicit in such nutritional manipulation. Concern has centred around three potential hazards. The most serious of these is the possibility that rigorous dietary regimens may be seriously deficient in phenylalanine for meeting the requirements of rapid physical growth which could, in fact, impair the cerebral development of patients whom the diets are designed to protect. That this may be a valid concern is suggested by the work of Fuller and Shuman (1969) has been speculation that totally synthetic diets provide inadequate amounts of certain unspecified nutrients found only in natural foodstuffs. Finally, it has been suspected that imbalanced amino acid composition may lead to poor acceptance of the dietary preparation of interfere with normal protein synthesis. Harper (1958) and others have observed a consistent depression of food intake and retarded growth in rats fed diets that are very deficient in a single amino acid. It has been suggested that 'the changed blood amino acid pattern serves as a signal that activates an appetite-regulating mechanism, while the pattern is an indirect reflection of some more subtle change, possibly at sites of protein synthesis' (Yoshida et al., 1966) . Controlled observations have not been made to determine whether humans are similarly affected.
The present study will attempt to deal with the following questions.
(1) Can a chemically-defined totally synthetic diet meet the complex nutritional demands and the overall health requirements of a rapidly growing phenylketonuric patient over a period of years?
( View, California. This synthetic preparation* was based on a chemically-defined liquid diet, originally designed for animal experimentation (Greenstein et al., 1957) and later adapted for human use (Winitz et al., 1965) . It was provided as a powder which was mixed with water. The resulting orange-flavoured liquid proved acceptable as the sole source of nutrition after a period of acclimatization of 1 to 4 weeks. Table I indicates its composition.
The caloric intake was adjusted upward until a steady weight gain was achieved in each patient-usually at about 3500-4000 calories per day. Later adjustments downward were necessary to avoid obesity while maintaining statural growth. On this empirical basis the present caloric intake which ranges between 2400 and 3000 calories per day was established over a 6-month period. The final intakes provided about 53 Cal/kg for the oldest children (17 5 years of age) and 76 Cal/kg for the youngest (12 years of age). A 50-kg adolescent male, for example, was provided with 2700 ml (2700 Cal) of the diet per day, which supplied 8J8 g available nitrogen in the form of L-amino acids and glycine, 610 g carbohydrate in the form of glucose polymer, and 2 g fat in the form of safflower oil.
(B) Synthetic diet with low-phenylalanine, hightyrosine content. Diet A was modified in only two ways: 80% of the L-phenylalanine was removed and replaced on an equimolar basis by L-tyrosine which kept the diet isonitrogenous and isocaloric. Thus the 50 kg boy, referred to above, who received 2700 Cal, found his phenylalanine intake reduced from 2 8 g/day to 0 55 g/day while his tyrosine intake was increased from 3 1 g to 5-5 g/day. Because of limited supply, this diet was administered to the 4 male patients only. Dietary intake and weight were recorded daily for 6 months after the initiation of the low phenylalanine regimen.
(C) Adjusted low phenylalanine, high tyrosine diet.
The phenylalanine content of Diet B was modified by replacing an appropriate amount with Diet A (to increase) or 'no phenylalanine', high tyrosine diet (to decrease). This permitted the final dietary adjustment necessary to maintain blood phenylalanine levels at 3-5 mg/100 ml. (2) Electrophysiological. Standard electroencephalograms were obtained under postprandial conditions just before shifting to the low phenylalanine diet; then, 3 and 6 months after the diet was begun.
Results and Discussion Physical examination. At no time was there a noteworthy change in status by physical examination except for the signs accompanying an exotic attack of appendicitis which followed the ingestion of a metal screw which subsequently lodged in the appendix of the only female patient in the study (Case 5 (Mosier, Grossman, and Dingman, 1965) . Other studies find, more specifically, that 35 to 50% of retardates 'without obvious organic damage' fall more than 2 SD below the norm for height (Rundle and Sylvester, 1962; Bailit and Whelan, 1967) .
In this context, therefore, the relatively normal growth increments on chemical diets (noted in Fig. 2) are the more convincing.
Effect of imbalanced diet
Changes in dietary intake and weight. Table II shows the average weight for each of the 6 months before the low phenylalanine diet and for each of the 6 months after its initiation. It will be noted that the weights of each of the five patients remained constant or increased slightly-in addition to the aforementioned normal statural gain. There was no detectable change in intake after the low phenylalanine diet was started. In short, these data provide no evidence that the imbalanced character of the diet altered its acceptability or nutritional efficiency.
Phenylalanine concentrations in plasma. Fig.  3 indicates the change in blood phenylalanine levels on the low phenylalanine synthetic diet. It will be observed that the fasting blood levels of phenylalanine correlate well with the phenylalanine intake before restriction. After the 80% reduction in dietary phenylalanine, one patient (Case 2), whose new phenylalanine intake of 10 * 6 mg/kg per day was well below that of the other patients, reached near normal blood levels in one week. Another (Case 1) who received 14 mg phenylalanine/kg per day, did not reach a blood phenylalanine concentration of 4 mg/100 ml for 17 days. Cases 1 and 2 were maintained between 3-5 mg/100 ml with daily supplements of 389 mg and 83 mg phenylalanine which provided 20 1 mg and 17-8 mg/kg per day, respectively. On lower phenylalanine intakes (14 and 15 mg phenylalanine/kg per day, respectively) Cases 3 and 4 were unable to establish blood levels below 10 mg/100 ml. After declining to 12 mg/100 ml 0-i in 14 days, the phenylalanine concentration in Case 3 dropped very gradually to 10 mg/100 ml, while in the blood of Case 4 the level rose slightly from a low of 12 mg/100 ml and equilibrated at 16 mg/ 100 ml. By further reducing the phenylalanine intake of Case 4 from 625 mg to 312 mg the blood phenylalanine was brought down to 4 mg/100 ml in 2 weeks. Case 3 reached this therapeutic level when his intake was reduced from 500 mg to 396 mg. Thus, the phenylalanine requirements for Cases 3 and 4 were only 12-8 mg and 6 9 mg/kg per day, respectively.
A major contributor to the apprehension surrounding the administration of phenylalanine- Change in neurological status. Anecdotal nursing records give strong evidence of behaviour improvement in Cases 1 and 4. Case 4 had a particularly dramatic change in mood and temperament. As his blood phenylalanine concentration declined to about 12 mg/100 ml, his personality dramatically changed: he was transformed from a whining, irritable child to one who was smiling and responsive. Case 1 also showed a marked improvement in mood with a reduction in his frequent episodes of crying and irritability. This was noted after about 10 days of the low phenylalanine regimen, at which time his blood level was also 10-12 mg/100 ml. At about the same point Case 3 also had some improvement in temperament and in ability to sustain attention while at play. However, Case 2 showed no perceptible change in behaviour until the phenylalanine concentration fell below 5 mg/100 ml.
Electrophysiological change. The 3 patients with early behavioural improvement showed objective evidence of EEG improvement also, consisting primarily of readily demonstrable decreases in paroxsymal slow wave activity. This was true on both the 3-and 6-month post-treatment records.
Further evidence of electrophysiological improvement in the summated cortical responses evoked by patterned flash has been observed after plasma phenylalanine levels returned to normal. Preliminary data have been previously noted (Marcus, 1970) and will subsequently be reported in detail. The most consistent therapeutic response was significant shortening of the abnormally prolonged latency times for the visually evoked responses (VER). The decrease in conduction time was most obvious in Cases 3 and 4: they each had a steep drop in latency when blood phenylalanine concentrations fell below 12 mg/100 ml, which was also accompanied by an abrupt increase in blood serotonin and improved behaviour. Case 2, on the other hand, showed a delay in the appearance of electrophysiological and behavioural changes.
Of interest in regard to the neurological improvement are the associated changes in whole blood serotonin, which is thought to be a modulator of nervous system activity. We have noted that serotonin levels usually rise steeply as plasma phenylalanine concentrations approach 12 mg/100 ml (unpublished data). Cases 3 and 4 displayed the most rapid and the highest rises among the 4 treated patients, from 150 to 320 ng per ml. Case 2's serotonin value (125 ng/ml) did not change significantly until the blood phenylalanine dropped below 5 mg/100 ml, at which time the serotonin concentration rose to 270 ng/ml and the VER latency decreased.
These data provide strong presumptive evidence that it is possible to maintain good nutrition and to improve central nervous system function in certain previously untreated, profoundly retarded phenylketonurics, when phenylalanine concentrations are reduced below 12 mg/100 ml using a synthetic dietary preparation. With the help of objective tests of CNS function (such as the VER), it may be practical to identify those patients of any age who will respond to phenylalanine restriction. In such cases, it would be helpful to determine the maximum phenylalanine level that will still permit the observed neurological improvement in order to permit effective dietary planning. 
